Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-24-015446

Chief Executive Officer sold 60,000 shares at an average $59.26 ($3,555,400)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Santos da Silva Jorge · Chief Executive Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-15 Sale : show line 1 in the form 10b5-1 −20,000 $60.18 $1,203,600 3,147,554 D
2024-02-16 Sale : show line 2 in the form 10b5-1 −20,000 $60.15 $1,203,000 3,127,554 D
2024-02-20 Sale : show line 3 in the form 10b5-1 −20,000 $57.44 $1,148,800 3,107,554 D
Open-market sales · 60,000 sh · avg $59.26 · $3,555,400
Loading xslF345X05/ownership.xml…